A Two-part, Single Centre, Open-label, Randomised, Single Dose, Two-period, Crossover, Relative Bioavailability Study of Infacort® Versus Cortef® in Dexamethasone-suppressed Healthy Adult Male and Female Subjects in the Fasted and Fed States.
Phase of Trial: Phase I
Latest Information Update: 25 May 2018
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Adrenal insufficiency
- Focus Pharmacokinetics
- Sponsors Diurnal
- 14 May 2018 Planned number of patients changed from 24 to 48.
- 14 May 2018 Planned End Date changed from 1 May 2018 to 8 Jun 2018.
- 14 May 2018 Planned primary completion date changed from 1 May 2018 to 8 Jun 2018.